Understanding the molecular drivers of disease heterogeneity in Crohn's disease using multi-omic data integration and network analysis
Open accessThe DOI matches its Crossref record; 105 of the 105 references it cites were found in a registry or an index.
Abstract
Crohn’s disease (CD), a form of inflammatory bowel disease (IBD), is characterized by heterogeneity along multiple clinical axes, which in turn impacts disease progression and treatment modalities. Using advanced data integration approaches and systems biology tools, we studied the contribution of CD susceptibility variants and gene expression in distinct peripheral immune cell subsets (CD14+ monocytes and CD4+ T cells) to relevant clinical traits. Our analyses revealed that most clinical traits capturing CD heterogeneity could be associated with CD14+ and CD4+ gene expression rather than disease susceptibility variants. By disentangling the sources of variation, we identified molecular features that could potentially be driving the heterogeneity of various clinical traits of CD patients. Further downstream analyses identified contextual hub proteins such as genes encoding barrier functions, antimicrobial peptides, chemokines, and their receptors, which are either targeted by drugs used in CD or other inflammatory diseases or are relevant to the biological functions implicated in disease pathology. These hubs could be used as cell type–specific targets to treat specific subtypes of CD patients in a more individualized approach based on the underlying biology driving their disease subtypes. Our study highlights the importance of data integration and systems approaches to investigate complex and heterogeneous diseases such as IBD.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Pioneering studies have shown that an integrative approach can identify patient subgroups (phenomapping) for tailored disease management.”
From Artificial intelligence and endo-histo-omics: new dimensions of precision endoscopy and histology in inflammatory bowel disease (2024) · cites this paper as [83]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The Molecular Signatures Database Hallmark Gene Set Collection
Liberzon, A., Birger, C., Thorvaldsdóttir, H., Ghandi, M., Mesirov, J. P., & Tamayo, P. (2015) · Cell Systems · doi:10.1016/j.cels.2015.12.004 · Cited by 13,807
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
Springer, T. A. (1994) · Cell · doi:10.1016/0092-8674(94)90337-9 · Cited by 6,929
A General Framework for Weighted Gene Co-Expression Network Analysis
Zhang, B., & Horvath, S. (2005) · Statistical Applications in Genetics and Molecular Biology · doi:10.2202/1544-6115.1128 · Cited by 5,684
Host–microbe interactions have shaped the genetic architecture of inflammatory bowel disease
The International IBD Genetics Consortium (IIBDGC), Jostins, L., Ripke, S., Weersma, R. K., Duerr, R. H., McGovern, D. P., Hui, K. Y., Lee, J. C., Philip Schumm, L., Sharma, Y., et al. (2012) · Nature · doi:10.1038/nature11582 · Cited by 4,722
Silverberg, M. S., Satsangi, J., Ahmad, T., Arnott, I. D., Bernstein, C. N., Brant, S. R., Caprilli, R., Colombel, J.-F., Gasche, C., Geboes, K., et al. (2005) · Canadian Journal of Gastroenterology · doi:10.1155/2005/269076 · Cited by 3,409
Self-citationScale-Free Networks: A Decade and Beyond
Barabási, A.-L. (2009) · Science · doi:10.1126/science.1173299 · Cited by 2,109
Genetic and epigenetic fine mapping of causal autoimmune disease variants
Farh, K. K.-H., Marson, A., Zhu, J., Kleinewietfeld, M., Housley, W. J., Beik, S., Shoresh, N., Whitton, H., Ryan, R. J. H., Shishkin, A. A., et al. (2015) · Nature · doi:10.1038/nature13835 · Cited by 1,956
Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia.
de Jong, M. D., Simmons, C. P., Thanh, T. T., Hien, V. M., Smith, G. J. D., Chau, T. N. B., Hoang, D. M., Van Vinh Chau, N., Khanh, T. H., Dong, V. C., et al. (2006) · Nature Medicine · doi:10.1038/nm1477 · Cited by 1,858
Maaser, C., Sturm, A., Vavricka, S. R., Kucharzik, T., Fiorino, G., Annese, V., Calabrese, E., Baumgart, D. C., Bettenworth, D., Borralho Nunes, P., et al. (2019) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjy113 · Cited by 1,823
Self-citationCD4 T cells: fates, functions, and faults
Zhu, J., & Paul, W. E. (2008) · Blood · doi:10.1182/blood-2008-05-078154 · Cited by 1,798
Cited by
Verstockt, B., Noor, N. M., Marigorta, U. M., Pavlidis, P., Deepak, P., Ungaro, R. C., Fiocchi, C., Torres, J., & Scharl, M. M. (2021) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjab050 · Cited by 85
Self-citationGenetic heterogeneity: Challenges, impacts, and methods through an associative lens
Woodward, A., Urbanowicz, R. J., Naj, A. C., & Moore, J. H. (2022) · Genetic Epidemiology · doi:10.1002/gepi.22497 · Cited by 76
Iacucci, M., Santacroce, G., Zammarchi, I., Maeda, Y., Del Amor, R., Meseguer, P., Kolawole, B. B., Chaudhari, U., Di Sabatino, A., Danese, S., et al. (2024) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(24)00053-0 · Cited by 73
Omics and Multi-Omics in IBD: No Integration, No Breakthroughs
Fiocchi, C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms241914912 · Cited by 67
How Do We Predict a Patient’s Disease Course and Whether They Will Respond to Specific Treatments?
Verstockt, B., Parkes, M., & Lee, J. C. (2022) · Gastroenterology · doi:10.1053/j.gastro.2021.12.245 · Cited by 64
Self-citationNowak, J. K., Adams, A. T., Kalla, R., Lindstrøm, J. C., Vatn, S., Bergemalm, D., Keita, Å. V., Gomollón, F., Jahnsen, J., Vatn, M. H., et al. (2022) · Journal of Crohn's and Colitis · doi:10.1093/ecco-jcc/jjac033 · Cited by 51
Vlachavas, E., Bohn, J. R., Ückert, F., & Nürnberg, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22062822 · Cited by 38
Holistic healthcare in inflammatory bowel disease: time for patient-centric approaches?
Sudhakar, P., Wellens, J., Verstockt, B., Ferrante, M., Sabino, J., & Vermeire, S. (2022) · Gut · doi:10.1136/gutjnl-2022-328221 · Cited by 38
Self-citationBourgonje, A. R., van Goor, H., Faber, K. N., & Dijkstra, G. D. H. (2023) · Clinical and Translational Gastroenterology · doi:10.14309/ctg.0000000000000579 · Cited by 31
Juzėnas, S., Hübenthal, M., Lindqvist, C. M., Kruse, R. L., Steiert, T. A., Degenhardt, F. C., Schulte, D. M., Nikolaus, S., Zeißig, S., Bergemalm, D., et al. (2022) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjac003 · Cited by 29
Tailoring Multi-omics to Inflammatory Bowel Diseases: All for One and One for All
Sudhakar, P., Alsoud, D., Wellens, J., Verstockt, S., Arnauts, K., Verstockt, B., & Vermeire, S. (2022) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjac027 · Cited by 28
Self-citationVerstockt, B., Verstockt, S., Cremer, J., Sabino, J., Ferrante, M., Vermeire, S., & Sudhakar, P. (2023) · BMJ Open Gastroenterology · doi:10.1136/bmjgast-2022-001003 · Cited by 24
Self-citationIBD Systems Biology Is Here to Stay
Fiocchi, C., & Iliopoulos, D. (2021) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaa343 · Cited by 23
Neonatal microbiome in the multiomics era: development and its impact on long-term health
Neu, J., & Stewart, C. J. (2025) · Pediatric Research · doi:10.1038/s41390-025-03953-x · Cited by 22
Dudzińska, E., Mądro, A., Sauer, A. K., Grabrucker, A. M., & Strachecka, A. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s487349 · Cited by 22
Ceccato, H. D., Silva, T., Genaro, L. M., Silva, J. F., de Souza, W. M., Oliveira, P. D. S. P., de Azevedo, A. T., Ayrizono, M. D. L. S., & Leal, R. F. (2025) · American Journal of Translational Research · doi:10.62347/xill3707 · Cited by 20
O'Brien, C. L., SUMMERS, K. M., Martin, N. M., Carter‐Cusack, D., Yang, Y., Barua, R., Dixit, O. V. A., Hume, D. A., & Pavli, P. (2024) · Human Genetics · doi:10.1007/s00439-024-02642-9 · Cited by 17
Gene coexpression networks reveal a broad role for lncRNAs in inflammatory bowel disease
Johnson, J. L., Sargsyan, D., Neiman, E. M., Hart, A. B., Stojmirović, A., Kosoy, R., Irizar, H., Suárez‐Fariñas, M., Song, W., Argmann, C., et al. (2024) · JCI Insight · doi:10.1172/jci.insight.168988 · Cited by 17
Big Data in Gastroenterology Research
Alizadeh, M. A., Moura, N. S., Schledwitz, A., Patil, S. A., Ravel, J., & Raufman, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032458 · Cited by 17
Chen, Y., Gao, Y., Huo, K., Jin, Z., Wang, W., Zan, X., Liu, Y., Zhu, L., & Yang, J. (2025) · Advanced Science · doi:10.1002/advs.202500001 · Cited by 17
AI-enabled ‘endo-histo-omics’: breaking down intestinal barriers in IBD
Iacucci, M., Maeda, Y., Santacroce, G., & Ghosh, S. K. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01051-1 · Cited by 14
The use of vitamin D for patients with inflammatory bowel diseases: A systematic review
Matias, J. N., Lima, V. M., Nutels, G. S., Laurindo, L. F., Barbalho, S. M., Goulart, R. D. Á., Araújo, A. C., Suzuki, R. B., & Guiguer, É. L. (2022) · International Journal for Vitamin and Nutrition Research · doi:10.1024/0300-9831/a000764 · Cited by 14
Anti-TNF Therapies Suppress Adipose Tissue Inflammation in Crohn’s Disease
Boronat-Toscano, A., Monfort-Ferré, D., Menacho, M., Caro, A., Bosch, R., Espina, B., Algaba‐Chueca, F., Saera-Vila, A., Moliné, A., Martí, M., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231911170 · Cited by 13
Hassan, S. A., Perry, C. L., Carey, P. J., Colohan, D., Eltaher, M. G., Dawoud, N., Elkammar, M., Rasheed, W., Mayne, C., Stuffelbeam, A., et al. (2024) · Crohn s & Colitis 360 · doi:10.1093/crocol/otae080 · Cited by 12
Co-expression of fibrotic genes in inflammatory bowel disease; A localized event?
Dovrolis, N., Filidou, E., Tarapatzi, G., Kokkotis, G., Spathakis, M., Kandilogiannakis, L., Drygiannakis, I., Valatas, V., Arvanitidis, K. I., Karakasiliοtis, I., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.1058237 · Cited by 11
Decoding IBD progression: a dynamic biomarker atlas for personalized disease stratification
Tao, Y., Wang, L.-F., Pan, L., Sun, R., Li, Y.-J., Sun, M., Zhang, L.-J., Yang, L.-H., Jin, J.-J., & Zhong, X. (2025) · Journal of Translational Medicine · doi:10.1186/s12967-025-07024-x · Cited by 8
Shaw, V. R., Byun, J., Pettit, R. W., Hou, J. K., Walsh, K. M., Han, Y., & Amos, C. I. (2023) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izad269 · Cited by 7
Sudhakar, P., Keersmaekers, B., Stiers, R., Dycker, E. D., Geens, P., Paps, A., Lambrechts, T., Wellens, J., Sabino, J., Ferrante, M., et al. (2022) · GastroHep · doi:10.1155/2022/9919542 · Cited by 6
Self-citationAre We Ready to Reclassify Crohn’s Disease Using Molecular Classification?
Kamal, S., Parkash, N., Beattie, W., Christensen, B., & Segal, J. P. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12185786 · Cited by 6
Rimmer, P. J., & Iqbal, T. H. (2023) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2023.101877 · Cited by 6
Fu, M., Aihemaiti, D., Fu, H., Li, N., Yuan, Y., & Ye, M. (2024) · Journal of Inflammation Research · doi:10.2147/jir.s458951 · Cited by 5
Kedari, N., Dey, U., Sreenija, D., Paul, S., Shakya, S., Biswas, R., Ramaiah, S., & Anbarasu, A. (2026) · SLAS TECHNOLOGY · doi:10.1016/j.slast.2026.100452 · Cited by 4
Blood transcriptomics identifies FEZ1 as a potential biomarker for inflammatory bowel disease
Delkhah, A. M. D. (2025) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2025.109742 · Cited by 4
Li, B., Hu, P., Liang, H., Zhao, X., Zhang, A., Xu, Y., Zhang, B., & Zhang, J. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1434369 · Cited by 3
Current approaches to the surgical management of Crohn’s disease in Australia and New Zealand
Zheng, S., Edmundson, A., & Clark, D. A. (2025) · International Journal of Colorectal Disease · doi:10.1007/s00384-024-04778-6 · Cited by 3
Therapeutic Drug Monitoring in Inflammatory Bowel Disease
Fahad, A., Sheikh, S. J., Munir, M., Cheema, A. Y., Khan, M. A., Tahir, H., Rajpar, R., Kasem, A., Bhogoju, S., Qureshi, H., et al. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1002197 · Cited by 3
Leukocyte dysfunction and reduced CTLA-4 expression are associated with perianal Crohn’s disease
Duarte-Silva, M., Parra, R. S., Feitosa, M. R., Nardini, V., Maruyama, S. R., da Rocha, J. J. R., Féres, O., & Cardoso, C. R. D. B. (2024) · Clinical & Experimental Immunology · doi:10.1093/cei/uxae027 · Cited by 3
Sun, L., Sun, X., Qiao, C., Lu, Y., Li, Q., Wang, Q., & Gao, H. (2026) · Saudi Journal of Gastroenterology · doi:10.4103/sjg.sjg_384_25 · Cited by 2
Metabolomics Approach to Identify Biomarkers of Epidemic Diseases
Mina, P. R. (2023) · Springer eBooks · doi:10.1007/978-3-031-39094-4_4 · Cited by 2
Su, Z., Fang, J., Wang, S., & Liu, G. (2026) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2026.2623245 · Cited by 1
Almutawif, Y. A., & Eid, H. M. A. (2026) · Archives of Microbiology · doi:10.1007/s00203-026-05051-w · Cited by 1
Trends in the development of dietary supplements and biologically active food additives
Lukyanenko, M. V., Donchenko, L. V., Vasilev, A. A., Sobol, I. V., Варивода, А. А., & (Grushina), E. Y. U. (2025) · Proceedings of the Voronezh State University of Engineering Technologies · doi:10.20914/2310-1202-2025-4-165-172 · Cited by 1
Miscellaneous Considerations in Inflammatory Bowel Disease
Gaduputi, V. V. (2023) · IntechOpen eBooks · doi:10.5772/intechopen.1000411
VIBRATO’s Symphony: Orchestrating Biomarker Harmony for Ritlecitinib in UC Therapy
Verstockt, B. (2024) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjae103
Self-citationNanocarriers in inflammatory bowel disease and colorectal cancer
Wal, A., Wal, P., Singh, D., & Singh, M. R. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-24806-1.00024-8
Sudhakar, P., Steen, K. V., Mallick, A. I., & Arnauts, K. (2025) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2025.1665390
Self-citationA Conceptual Model for an Ontology-Based Dietary Recommendation Plan in Crohn’s Disease
Almehmadi, R., Alsobhi, A. Y., & Almatrafi, O. (2025) · International Journal of Advanced Computer Science and Applications · doi:10.14569/ijacsa.2025.0161152
Höper, H. (2025) · MACAU: Open Access Repository of Kiel University
Etude du processus pathogénique associé à la maladie de Chagas à l'aide d'analyses multi-omiques
Brochet, P. (2023) · theses.fr (ABES) · doi:10.70675/4d994cc7z7b36z4bdfz8296za6b686a06b76
Alvear, D. A. M., Estévez, A. R. M., Vera, P. M. B., Medrano, M. P. M., Pazmiño, M. C. B., Moya, D. S. P., Trujillo, J. F. C., & Marrett, F. M. O. (2026) · Ibero-American Journal of Health Science Research · doi:10.56183/iberojhr.v6i1.949
VAV3 is associated with atherosclerosis and ox-LDL-induced endothelial dysfunctional remodeling
Wang, G., Pu, C., Li, Q., Liu, Q., Wan, X., Deng, J., Dai, M., Xie, B., Huang, L., & Zhao, Y. (2026) · Microvascular Research · doi:10.1016/j.mvr.2026.104966
Gómez-Bris, R., Ortega-Zapero, M., Herrero‐Fernández, B., Fanjul, V., de Vega, N. D. L. M., de Bustos, S. M., Moreno-Aperribay, I., Zorita, V., Sánchez-Martinez, H., Polari, L., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.03.735779
Dovrolis, N., Filidou, E., Tarapatzi, G., Kokkotis, G., Spathakis, M., Kandilogiannakis, L., Drygiannakis, I., Valatas, V., Arvanitidis, K., Karakasiliotis, I., et al. (2022) · doi:10.3389/fimmu.2022.1058237.s001
Metadata
- Authors
- Sudhakar, P., Verstockt, B., Cremer, J., Verstockt, S., Sabino, J., Ferrante, M., & Vermeire, S.
- Affiliations
- Department of Chronic Diseases, Metabolism and Ageing, Translational Research Center for Gastrointestinal Disorders (TARGID)
- Universitair Ziekenhuis Leuven (BE)
- KU Leuven (BE)
- Corresponding author
- Vermeire, Séverine
- ORCID
- Venue
- Inflammatory Bowel Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-12-14
- Volume
- 27
- Issue
- 6
- Pages
- 870-886
- ISSN
- 1078-0998 (ISSN-L)
- 1536-4844
- PMC
- PMC8128416
- OpenAlex
- W3112595545
- Cited by
- 49
- References
- 105
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 9 · 2023: 11 · 2022: 10 · 2021: 3
- FWCI
- 3.51
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Inflammatory Bowel Diseases (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Lirias (KU Leuven) (acceptedVersion, cc-by-nc)
- Lirias (KU Leuven) (submittedVersion, other-oa)
- Funders
- European Research Council (ERC-2015-AdG, 694679)
- Topics
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- Crohn's disease, disease heterogeneity
- MeSH terms
- Antimicrobial Peptides, Crohn Disease, Humans, CD4-Positive T-Lymphocytes, Chemokines, Systems Biology
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.